BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23836481)

  • 1. Comprehensive assessment of prognostic markers for sinonasal squamous cell carcinoma.
    Takahashi Y; Bell D; Agarwal G; Roberts D; Xie TX; El-Naggar A; Myers JN; Hanna EY
    Head Neck; 2014 Aug; 36(8):1094-102. PubMed ID: 23836481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
    Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
    Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
    Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT
    Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
    Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
    J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
    Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.
    Gately K; Forde L; Cuffe S; Cummins R; Kay EW; Feuerhake F; O'Byrne KJ
    Clin Lung Cancer; 2014 Jan; 15(1):58-66. PubMed ID: 24210543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene amplification and protein overexpression of EGFR and ERBB2 in sinonasal squamous cell carcinoma.
    López F; Llorente JL; Oviedo CM; Vivanco B; Marcos CÁ; García-Inclán C; Scola B; Hermsen MA
    Cancer; 2012 Apr; 118(7):1818-26. PubMed ID: 22009799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis.
    Laimer K; Spizzo G; Gastl G; Obrist P; Brunhuber T; Fong D; Barbieri V; Jank S; Doppler W; Rasse M; Norer B
    Oral Oncol; 2007 Feb; 43(2):193-8. PubMed ID: 16854613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX2 expression in hypopharyngeal, laryngeal, and sinonasal squamous cell carcinoma.
    González-Márquez R; Llorente JL; Rodrigo JP; García-Pedrero JM; Álvarez-Marcos C; Suárez C; Hermsen MA
    Hum Pathol; 2014 Apr; 45(4):851-7. PubMed ID: 24656096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas.
    Imamhasan A; Mitomi H; Saito T; Hayashi T; Takahashi M; Kajiyama Y; Yao T
    Hum Pathol; 2012 Nov; 43(11):2012-23. PubMed ID: 22607702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin.
    Yamamoto Y; Yamai H; Seike J; Yoshida T; Takechi H; Furukita Y; Kajiura K; Minato T; Bando Y; Tangoku A
    Ann Surg Oncol; 2012 Mar; 19(3):757-65. PubMed ID: 21947696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between epidermal growth factor receptor gene copy number and protein expression in oral cavity squamous cell carcinoma.
    Huang SF; Cheng SD; Chien HT; Liao CT; Chen IH; Wang HM; Chuang WY; Wang CY; Hsieh LL
    Oral Oncol; 2012 Jan; 48(1):67-72. PubMed ID: 21831696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-protein signature accurately predicts lymph node metastasis and survival in oral squamous cell carcinoma.
    Zanaruddin SN; Saleh A; Yang YH; Hamid S; Mustafa WM; Khairul Bariah AA; Zain RB; Lau SH; Cheong SC
    Hum Pathol; 2013 Mar; 44(3):417-26. PubMed ID: 23026198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer.
    Hong A; Dobbins T; Lee CS; Jones D; Jackson E; Clark J; Armstrong B; Harnett G; Milross C; O'Brien C; Rose B
    Eur J Cancer; 2010 Jul; 46(11):2088-96. PubMed ID: 20537890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus infection is strictly associated with the metastatic spread of sinonasal squamous-cell carcinomas.
    Doescher J; Piontek G; Wirth M; Bettstetter M; Schlegel J; Haller B; Brockhoff G; Reiter R; Pickhard A
    Oral Oncol; 2015 Oct; 51(10):929-34. PubMed ID: 26272275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy.
    Hitt R; Ciruelos E; Amador ML; Benito A; Sanchez JJ; Ballestin C; Cortes-Funes H
    Eur J Cancer; 2005 Feb; 41(3):453-60. PubMed ID: 15691646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
    Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of epidermal growth factor receptor, mesenchymal-epithelial transition factor, and insulin-like growth factor receptor 1 expression on survival of patients with oral and oropharyngeal cancer.
    Perisanidis C; Wrba F; Brandstetter A; Kornek G; Mitchell D; Seemann R; Selzer E; Ewers R; Filipits M
    Br J Oral Maxillofac Surg; 2013 Apr; 51(3):234-40. PubMed ID: 22889668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.